Base-edited hematopoietic stem and progenitor cells: Clinical Trials

4 trials of Base-edited hematopoietic stem and progenitor cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 enrolling by invitation, 2 recruiting. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Enrolling by invitation 2, Recruiting 2
Phase 24Enrolling by invitation 2, Recruiting 2

Follow Base-edited hematopoietic stem and progenitor cells: new trials by email Literature Review of Base-edited hematopoietic stem and progenitor cells trials Research Report on Base-edited hematopoietic stem and progenitor cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM
Busulfan, Palifermin, Plerixafor - WHIM, Warts
Phase 1 / Phase 2Enrolling by invitationNational Institute of Allergy and Infectious Diseases (NIAID)102026-10-212026-10-27
Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study
Base-edited hematopoietic stem and progenitor cells, Alemtuzumab, Sirolimus - CD40L-HyperIgM Syndrome
Phase 1 / Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)12025-07-162026-07-31
Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy
Plerixafor, Filgrastim, Palifermin - X-linked Severe Combined Immunodeficiency, X-SCID
Phase 1 / Phase 2Enrolling by invitationNational Institute of Allergy and Infectious Diseases (NIAID)182025-05-092026-10-13
Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
Campath, Sirolimus, Base-edited hematopoietic stem and progenitor cells - Chronic Granulomatous Disease (CGD), X-Linked Chronic Granulomatous Disease
Phase 1 / Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)152024-04-172026-08-13

Conditions studied

Agammaglobulinemia (1)  ·  Granulomatous Disease, Chronic (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Warts (1)  ·  X-Linked Combined Immunodeficiency Diseases (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (4)

Countries

United States (4)

Top investigators

Suk S De Ravin, M.D. (4)

Results publications

PMID 39413163